Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 9.323
1.
Clin Neurophysiol ; 161: 222-230, 2024 May.
Article En | MEDLINE | ID: mdl-38522268

OBJECTIVE: We compared the effective networks derived from Single Pulse Electrical Stimulation (SPES) in intracranial electrocorticography (ECoG) of awake epilepsy patients and while under general propofol-anesthesia to investigate the effect of propofol on these brain networks. METHODS: We included nine patients who underwent ECoG for epilepsy surgery evaluation. We performed SPES when the patient was awake (SPES-clinical) and repeated this under propofol-anesthesia during the surgery in which the ECoG grids were removed (SPES-propofol). We detected the cortico-cortical evoked potentials (CCEPs) with an automatic detector. We constructed two effective networks derived from SPES-clinical and SPES-propofol. We compared three network measures (indegree, outdegree and betweenness centrality), the N1-peak-latency and amplitude of CCEPs between the two effective networks. RESULTS: Fewer CCEPs were observed during SPES-propofol (median: 6.0, range: 0-29) compared to SPES-clinical (median: 10.0, range: 0-36). We found a significant correlation for the indegree, outdegree and betweenness centrality between SPES-clinical and SPES-propofol (respectively rs = 0.77, rs = 0.70, rs = 0.55, p < 0.001). The median N1-peak-latency increased from 22.0 ms during SPES-clinical to 26.4 ms during SPES-propofol. CONCLUSIONS: Our findings suggest that the number of effective network connections decreases, but network measures are only marginally affected. SIGNIFICANCE: The primary network topology is preserved under propofol.


Anesthetics, Intravenous , Electrocorticography , Nerve Net , Propofol , Humans , Propofol/pharmacology , Propofol/administration & dosage , Male , Female , Adult , Electrocorticography/methods , Anesthetics, Intravenous/pharmacology , Nerve Net/drug effects , Nerve Net/physiology , Young Adult , Middle Aged , Epilepsy/physiopathology , Epilepsy/surgery , Epilepsy/drug therapy , Brain/drug effects , Brain/physiology , Adolescent , Evoked Potentials/drug effects , Evoked Potentials/physiology , Electric Stimulation
2.
Life Sci ; 296: 120433, 2022 May 01.
Article En | MEDLINE | ID: mdl-35219696

AIMS: Neurotransmitter release from the synaptic vesicles can occur through two modes of exocytosis: "full-collapse" or "kiss-and-run". Here we investigated how increasing the nerve activity and pharmacological stimulation of adrenoceptors can influence the mode of exocytosis in the motor nerve terminal. METHODS: Recording of endplate potentials with intracellular microelectrodes was used to estimate acetylcholine release. A fluorescent dye FM1-43 and its quenching with sulforhodamine 101 were utilized to visualize synaptic vesicle recycling. KEY FINDINGS: An increase in the frequency of stimulation led to a decrease in the rate of FM1-43 unloading despite the higher number of quanta released. High frequency activity promoted neurotransmitter release via the kiss-and-run mechanism. This was confirmed by experiments utilizing (I) FM1-43 dye quencher, that is able to pass into the synaptic vesicle via fusion pore, and (II) loading of FM1-43 by compensatory endocytosis. Noradrenaline and specific α2-adrenoreceptors agonist, dexmedetomidine, controlled the mode of synaptic vesicle recycling at high frequency activity. Their applications favored neurotransmitter release via full-collapse exocytosis rather than the kiss-and-run pathway. SIGNIFICANCE: At the diaphragm neuromuscular junctions, neuronal commands are translated into contractions necessary for respiration. During stress, an increase in discharge rate of the phrenic nerve shifts the exocytosis from the full-collapse to the kiss-and-run mode. The stress-related molecule, noradrenaline, restricts neurotransmitter release in response to a high frequency activity, and prevents the shift in the mode of exocytosis through α2-adrenoceptor activation. This may be a component of the mechanism that limits overstimulation of the respiratory system during stress.


Exocytosis/physiology , Neuromuscular Junction/physiology , Receptors, Adrenergic/metabolism , Acetylcholine/metabolism , Adrenergic alpha-2 Receptor Agonists/pharmacology , Animals , Dexmedetomidine/pharmacology , Evoked Potentials/drug effects , Exocytosis/drug effects , Fluorescent Dyes/pharmacokinetics , Mice, Inbred BALB C , Neuromuscular Junction/drug effects , Neurotransmitter Agents/metabolism , Norepinephrine/metabolism , Norepinephrine/pharmacology , Pyridinium Compounds/pharmacokinetics , Quaternary Ammonium Compounds/pharmacokinetics , Receptors, Adrenergic, alpha-2/metabolism , Synaptic Vesicles/metabolism
3.
J Neurochem ; 160(3): 305-324, 2022 02.
Article En | MEDLINE | ID: mdl-34905223

Extracellular adenosine plays prominent roles in the brain in both physiological and pathological conditions. Adenosine can be generated following the degradation of extracellular nucleotides by various types of ectonucleotidases. Several ectonucleotidases are present in the brain parenchyma: ecto-nucleotide triphosphate diphosphohydrolases 1 and 3 (NTPDase 1 and 3), ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP 1), ecto-5'-nucleotidase (eN), and tissue non-specific alkaline phosphatase (TNAP, whose function in the brain has received little attention). Here we examined, in a living brain preparation, the role of these ectonucleotidases in generating extracellular adenosine. We recorded local field potentials evoked by electrical stimulation of the lateral olfactory tract in the mouse piriform cortex in vitro. Variations in adenosine level were evaluated by measuring changes in presynaptic inhibition generated by adenosine A1 receptors (A1Rs) activation. A1R-mediated presynaptic inhibition was present endogenously and was enhanced by bath-applied AMP and ATP. We hypothesized that inhibiting ectonucleotidases would reduce extracellular adenosine concentration, which would result in a weakening of presynaptic inhibition. However, inhibiting TNAP had no effect in controlling endogenous adenosine action and no effect on presynaptic inhibition induced by bath-applied AMP. Furthermore, contrary to our expectation, inhibiting TNAP reinforced, rather than reduced, presynaptic inhibition induced by bath-applied ATP. Similarly, inhibition of NTPDase 1 and 3, NPP1, and eN induced stronger, rather than weaker, presynaptic inhibition, both in endogenous condition and with bath-applied ATP and AMP. Consequently, attempts to suppress the functions of extracellular adenosine by blocking its extracellular synthesis in living brain tissue could have functional impacts opposite to those anticipated.


Cerebral Cortex/drug effects , Enzyme Inhibitors/pharmacology , Nucleotidases/antagonists & inhibitors , Synaptic Transmission/drug effects , 5'-Nucleotidase/antagonists & inhibitors , Adenosine/metabolism , Adenosine A1 Receptor Agonists/pharmacology , Adenosine Monophosphate/pharmacology , Adenosine Triphosphate/pharmacology , Alkaline Phosphatase/antagonists & inhibitors , Animals , Electric Stimulation , Evoked Potentials/drug effects , Female , Mice , Mice, Inbred C57BL , Olfactory Bulb/drug effects , Receptor, Adenosine A1/drug effects , Receptor, Adenosine A1/metabolism
4.
Toxicol Appl Pharmacol ; 430: 115725, 2021 11 01.
Article En | MEDLINE | ID: mdl-34536444

An effective in vitro screening assay to detect seizure liability in preclinical development can contribute to better lead molecule optimization prior to candidate selection, providing higher throughput and overcoming potential brain exposure limitations in animal studies. This study explored effects of 26 positive and 14 negative reference pharmacological agents acting through different mechanisms, including 18 reference agents acting on glutamate signaling pathways, in a brain slice assay (BSA) of adult rat to define the assay's sensitivity, specificity, and limitations. Evoked population spikes (PS) were recorded from CA1 pyramidal neurons of hippocampus (HPC) in the BSA. Endpoints for analysis were PS area and PS number. Most positive references (24/26) elicited a concentration-dependent increase in PS area and/or PS number. The negative references (14/14) had little effect on the PS. Moreover, we studied the effects of 15 reference agents testing positive in the BSA on spontaneous activity in E18 rat HPC neurons monitored with microelectrode arrays (MEA), and compared these effects to the BSA results. From these in vitro studies we conclude that the BSA provides 93% sensitivity and 100% specificity in prediction of drug-induced seizure liability, including detecting seizurogenicity by 3 groups of metabotropic glutamate receptor (mGluR) ligands. The MEA results seemed more variable, both quantitatively and directionally, particularly for endpoints capturing synchronized electrical activity. We discuss these results from the two models, comparing each with published results, and provide potential explanations for differences and future directions.


Convulsants/toxicity , Evoked Potentials/drug effects , Hippocampus/drug effects , Neurons/drug effects , Seizures/chemically induced , Toxicity Tests , Animals , Cells, Cultured , Female , Gestational Age , Glutamic Acid/metabolism , Hippocampus/embryology , Hippocampus/metabolism , Hippocampus/physiopathology , In Vitro Techniques , Ligands , Male , Neurons/metabolism , Rats, Sprague-Dawley , Rats, Wistar , Receptors, Metabotropic Glutamate/metabolism , Reproducibility of Results , Risk Assessment , Seizures/metabolism , Seizures/physiopathology , Signal Transduction
5.
Sci Rep ; 11(1): 9558, 2021 05 05.
Article En | MEDLINE | ID: mdl-33953209

Opioid inhibition of nociceptive stimuli varies in individuals and is difficult to titrate. We have reported the vascular stiffness value (K) as a standard monitor to quantify sympathetic response with high accuracy. On the contrary, among individuals, a considerable variation in the rate of change in K for constant pain has been observed. In this study, we proposed a new index, the minimum stimulus intensity value that evoked the response on K (MECK: Minimum Evoked Current of K), and evaluated its accuracy in predicting sympathetic response to nociceptive stimuli under constant opioid administration. Thirty patients undergoing open surgery under general anesthesia were included. After anesthetic induction, remifentanil was administered at a constant concentration of 2 ng/ml at the effect site followed by tetanus stimulation. MECK was defined as the minimal current needed to produce a change in K. MECK significantly (P < 0.001) correlated with the rate of change of systolic blood pressure during skin incision (ROCBP). Bland-Altman plot analysis using the predicted ROCBP calculated from MECK and the measured ROCBP showed that the prediction equation for ROCBP was highly accurate. This study showed the potential of MECK to predict blood pressure change during surgical incision under opioid analgesia.Clinical trial registration Registry: University hospital medical information network; Registration number: UMIN000041816; Principal investigator's name: Satoshi Kamiya; Date of registration: July 9th, 2019.


Analgesics, Opioid/administration & dosage , Blood Pressure/drug effects , Evoked Potentials/drug effects , Heart Rate/drug effects , Surgical Wound/physiopathology , Adult , Aged , Aged, 80 and over , Analgesics, Opioid/therapeutic use , Anesthesia, General , Blood Pressure/physiology , Evoked Potentials/physiology , Female , Heart Rate/physiology , Humans , Male , Middle Aged , Pain Measurement
6.
Sci Rep ; 11(1): 9567, 2021 05 05.
Article En | MEDLINE | ID: mdl-33953244

Functional studies in the central nervous system are often conducted using anesthesia. While the dose-dependent effects of anesthesia on neuronal activity have been extensively characterized in adults, little is known about the effects of anesthesia on cortical activity and cerebral blood flow in the immature central nervous system. Substitution of electrophysiological recordings with the less-invasive technique of optical intrinsic signal imaging (OIS) in vivo allowed simultaneous recordings of sensory-evoked functional response and local blood flow changes in the neonatal rat barrel cortex. Using OIS we characterize the effects of two widely used anesthetics-urethane and isoflurane. We found that both anesthetics suppressed the sensory-evoked optical intrinsic signal in a dose-dependent manner. Dependence of the cortical response suppression matched the exponential decay model. At experimental levels of anesthesia, urethane affected the evoked cortical response less than isoflurane, which is in agreement with the results of electrophysiological recordings demonstrated by other authors. Changes in oxygenation and local blood flow also showed negative correlation with both anesthetics. The high similarity in immature patterns of activity recorded in different regions of the developing cortex suggested similar principles of development regardless of the cortical region. Therefore the indicated results should be taken into account during functional explorations in the entire developing cortex. Our results also point to urethane as the anesthetic of choice in non-survival experimental recordings in the developing brain as it produces less prominent impairment of cortical neuronal activity in neonatal animals.


Anesthetics, Intravenous/pharmacology , Cerebrovascular Circulation/drug effects , Evoked Potentials/drug effects , Isoflurane/pharmacology , Somatosensory Cortex/drug effects , Urethane/pharmacology , Animals , Animals, Newborn , Female , Male , Rats , Rats, Wistar , Somatosensory Cortex/blood supply
7.
Neuropharmacology ; 190: 108557, 2021 06 01.
Article En | MEDLINE | ID: mdl-33848510

The intracellular accumulation of some amino acids (AAs), mainly glutamine, can contribute to brain edema observed during liver failure. We recently demonstrated that individual applications of high concentrations (10 mM) of some non-excitatory AAs increase the electrical resistance of hippocampal slices, indicating cell swelling. Therefore, we pondered whether an AA mixture's application might cause cell swelling at a physiological concentration range. In rat hippocampal slices, we carried out extra- and intracellular electrophysiological recordings and AAs analysis to address this question. We applied a mixture of 19 AAs at their plasmatic concentrations (Plasma solution: Ala, Gly, Gln, His, Ser, Tau, Thr, Arg, Leu, Met, Pro, Val, Asn, Cys, Phe, Ile, Lys, Tyr, and Trp). This solution was afterward divided into two according to the individual AAs at 10 mM concentration inducing synaptic potentiation (Plasma1, containing the first seven AAs of Plasma) or not (Plasma2, with the remaining AAs). Plasma application increased evoked field potentials requiring extracellular chloride. This effect was mimicked by the Plasma1 but not the Plasma2 solution. Plasma1-induced potentiation was independent of changes in release probability, basic electrophysiological membrane properties, and NMDAR activation. AAs in Plasma1 act cooperatively to accumulate intracellularly and to induce synaptic potentiation. In the presence of Plasma1, the reversible synaptic depression caused by a 40-min hypoxia period turned into an irreversible disappearance of synaptic potentials through an NMDAR-dependent mechanism. The presence of a system A transport inhibitor did not block Plasma1-mediated effects. These results indicate that cell swelling, induced by the accumulation of non-excitotoxic AAs through unidentified transporters, might foster deleterious effects produced by hypoxia-ischemia episodes.


Amino Acids/pharmacology , Brain Edema/metabolism , Evoked Potentials/drug effects , Hippocampus/drug effects , Hypoxia/metabolism , Synaptic Transmission/drug effects , Amino Acids/metabolism , Animals , Hippocampus/metabolism , Long-Term Potentiation , Long-Term Synaptic Depression , Rats , Receptors, N-Methyl-D-Aspartate/metabolism , Synaptic Transmission/physiology
8.
PLoS One ; 16(3): e0240147, 2021.
Article En | MEDLINE | ID: mdl-33690648

When presented with an oscillatory sensory input at a particular frequency, F [Hz], neural systems respond with the corresponding frequency, f [Hz], and its multiples. When the input includes two frequencies (F1 and F2) and they are nonlinearly integrated in the system, responses at intermodulation frequencies (i.e., n1*f1+n2*f2 [Hz], where n1 and n2 are non-zero integers) emerge. Utilizing these properties, the steady state evoked potential (SSEP) paradigm allows us to characterize linear and nonlinear neural computation performed in cortical neurocircuitry. Here, we analyzed the steady state evoked local field potentials (LFPs) recorded from the primary (S1) and secondary (S2) somatosensory cortex of anesthetized cats (maintained with alfaxalone) while we presented slow (F1 = 23Hz) and fast (F2 = 200Hz) somatosensory vibration to the contralateral paw pads and digits. Over 9 experimental sessions, we recorded LFPs from N = 1620 and N = 1008 bipolar-referenced sites in S1 and S2 using electrode arrays. Power spectral analyses revealed strong responses at 1) the fundamental (f1, f2), 2) its harmonic, 3) the intermodulation frequencies, and 4) broadband frequencies (50-150Hz). To compare the computational architecture in S1 and S2, we employed simple computational modeling. Our modeling results necessitate nonlinear computation to explain SSEP in S2 more than S1. Combined with our current analysis of LFPs, our paradigm offers a rare opportunity to constrain the computational architecture of hierarchical organization of S1 and S2 and to reveal how a large-scale SSEP can emerge from local neural population activities.


Analgesics/pharmacology , Evoked Potentials/drug effects , Somatosensory Cortex/physiology , Algorithms , Animals , Cats , Electrodes , Microarray Analysis , Signal-To-Noise Ratio
9.
Clin Neurophysiol ; 132(4): 914-921, 2021 04.
Article En | MEDLINE | ID: mdl-33636606

OBJECTIVE: How Parkinson's disease (PD) affects an individual's empathic capacity remains poorly understood. By using the event-related potential (ERP) technique, we sought to: (1) study the temporal dynamics of empathic responses in patients with PD; (2) explore whether dopaminergic medication modulates empathic processing. METHODS: Twenty-six patients with early-to-moderate PD (13 on- and 13 off-medication) and 14 healthy controls performed an empathy-for-pain paradigm test while we recorded their electroencephalography. The participants responded to neutral or painful pictures during an active empathic condition (pain judgment task) and a control condition that was manipulated by task demands (laterality judgment task). RESULTS: The ERP results demonstrated an early automatic frontal response and a late controlled parietal response to pain in healthy elderly controls. The observed early and late ERP responses were detected in the on-medication patients but not in the off-medication patients. CONCLUSIONS: PD is associated with deficits in both affective and cognitive empathic responses, dopaminergic medication may have the potential to alleviate these deficits. SIGNIFICANCE: This study helps to understand empathic deficits in patients with PD. Within-subject studies are required to reliably assess the effect of dopaminergic medication on empathic processing.


Antiparkinson Agents/therapeutic use , Brain/physiopathology , Empathy/physiology , Evoked Potentials/physiology , Pain/psychology , Parkinson Disease/physiopathology , Aged , Antiparkinson Agents/administration & dosage , Brain/drug effects , Electroencephalography , Empathy/drug effects , Evoked Potentials/drug effects , Female , Humans , Male , Middle Aged , Parkinson Disease/drug therapy , Parkinson Disease/psychology , Reaction Time/physiology
10.
Int J Mol Sci ; 22(2)2021 Jan 06.
Article En | MEDLINE | ID: mdl-33418933

Patients with Brugada syndrome (BrS) can show a leftward deviation of the frontal QRS-axis upon provocation with sodium channel blockers. The cause of this axis change is unclear. In this study, we aimed to determine (1) the prevalence of this left axis deviation and (2) to evaluate its cause, using the insights that could be derived from vectorcardiograms. Hence, from a large cohort of patients who underwent ajmaline provocation testing (n = 1430), we selected patients in whom a type-1 BrS-ECG was evoked (n = 345). Depolarization and repolarization parameters were analyzed for reconstructed vectorcardiograms and were compared between patients with and without a >30° leftward axis shift. We found (1) that the prevalence of a left axis deviation during provocation testing was 18% and (2) that this left axis deviation was not explained by terminal conduction slowing in the right ventricular outflow tract (4th QRS-loop quartile: +17 ± 14 ms versus +13 ± 15 ms, nonsignificant) but was associated with a more proximal conduction slowing (1st QRS-loop quartile: +12[8;18] ms versus +8[4;12] ms, p < 0.001 and 3rd QRS-loop quartile: +12 ± 10 ms versus +5 ± 7 ms, p < 0.001). There was no important heterogeneity of the action potential morphology (no difference in the ventricular gradient), but a left axis deviation did result in a discordant repolarization (spatial QRS-T angle: 122[59;147]° versus 44[25;91]°, p < 0.001). Thus, although the development of the type-1 BrS-ECG is characterized by a terminal conduction delay in the right ventricle, BrS-patients with a left axis deviation upon sodium channel blocker provocation have an additional proximal conduction slowing, which is associated with a subsequent discordant repolarization. Whether this has implications for risk stratification is still undetermined.


Ajmaline/therapeutic use , Brugada Syndrome/drug therapy , Sodium Channel Blockers/therapeutic use , Adult , Ajmaline/pharmacology , Brugada Syndrome/physiopathology , Electrocardiography , Evoked Potentials/drug effects , Female , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Humans , Male , Middle Aged , Sodium Channel Blockers/pharmacology , Ventricular Function/drug effects
11.
Int J Mol Sci ; 22(2)2021 Jan 19.
Article En | MEDLINE | ID: mdl-33478095

The α7 nicotinic acetylcholine receptor (α7 nAChR) is a ligand-gated ion channel that is involved in cognition disorders, schizophrenia, pain, and inflammation. Allosteric modulation of this receptor might be advantageous to reduce the toxicity in comparison with full agonists. Our previous results obtained with some hydroxy-chalcones, which were identified as positive allosteric modulators (PAMs) of α7 nAChR, prompted us to evaluate the potential of some structurally related naturally occurring flavonoids and curcuminoids and some synthetic curcumin analogues, with the aim of identifying new allosteric modulators of the α7 nAChR. Biological evaluation showed that phloretin, demethoxycurcumin, and bis-demethoxicurcuming behave as PAMs of α7 nAChR. In addition, some new curcumin derivatives were able to enhance the signal evoked by ACh; the activity values found for the tetrahydrocurcuminoid analog 23 were especially promising.


Diarylheptanoids/pharmacology , Flavonoids/pharmacology , alpha7 Nicotinic Acetylcholine Receptor/agonists , Allosteric Regulation/drug effects , Animals , Biological Products/pharmacology , Curcumin/analogs & derivatives , Curcumin/chemical synthesis , Curcumin/pharmacology , Diarylheptanoids/chemistry , Dose-Response Relationship, Drug , Electrophysiological Phenomena/drug effects , Evoked Potentials/drug effects , Female , Xenopus laevis
12.
J Psychopharmacol ; 35(1): 15-22, 2021 01.
Article En | MEDLINE | ID: mdl-32854568

BACKGROUND: Patients with schizophrenia have significant cognitive deficits, which may profoundly impair quality of life. These deficits are also evident at the neurophysiological level with patients demonstrating altered event-related potential in several stages of cognitive processing compared to healthy controls; within the auditory domain, for example, there are replicated alterations in Mismatch Negativity, P300 and Auditory Steady State Response. However, there are no approved pharmacological treatments for cognitive deficits in schizophrenia. AIMS: Here we examine whether the phosphodiesterase-4 inhibitor, roflumilast, can improve neurophysiological deficits in schizophrenia. METHODS: Using a randomised, double-blind, placebo-controlled, crossover design study in 18 patients with schizophrenia, the effect of the phosphodiesterase-4 inhibitor, roflumilast (100 µg and 250 µg) on auditory steady state response (early stage), mismatch negativity and theta (intermediate stage) and P300 (late stage) was examined using electroencephalogram. A total of 18 subjects were randomised and included in the analysis. RESULTS: Roflumilast 250 µg significantly enhanced the amplitude of both the mismatch negativity (p=0.04) and working memory-related theta oscillations (p=0.02) compared to placebo but not in the other (early- or late-stage) cognitive markers. CONCLUSIONS: The results suggest that phosphodiesterase-4 inhibition, with roflumilast, can improve electroencephalogram cognitive markers, which are impaired in schizophrenia, and that phosphodiesterase-4 inhibition acts at an intermediate rather than early or late cognitive processing stage. This study also underlines the use of neurophysiological measures as cognitive biomarkers in experimental medicine.


Aminopyridines , Benzamides , Cognition , Cognitive Dysfunction , Cyclic Nucleotide Phosphodiesterases, Type 4/metabolism , Evoked Potentials/drug effects , Schizophrenia , Adult , Aminopyridines/administration & dosage , Aminopyridines/adverse effects , Benzamides/administration & dosage , Benzamides/adverse effects , Cognition/drug effects , Cognition/physiology , Cognitive Dysfunction/drug therapy , Cognitive Dysfunction/etiology , Cognitive Dysfunction/physiopathology , Cognitive Dysfunction/psychology , Cross-Over Studies , Cyclopropanes/administration & dosage , Cyclopropanes/adverse effects , Double-Blind Method , Drug Monitoring/methods , Electroencephalography/drug effects , Electroencephalography/methods , Female , Humans , Male , Mental Processes/drug effects , Mental Processes/physiology , Phosphodiesterase 4 Inhibitors/administration & dosage , Phosphodiesterase 4 Inhibitors/adverse effects , Psychiatric Status Rating Scales , Schizophrenia/diagnosis , Schizophrenia/drug therapy , Schizophrenia/physiopathology , Treatment Outcome
13.
Cell Mol Neurobiol ; 41(2): 395-401, 2021 Mar.
Article En | MEDLINE | ID: mdl-32274597

The long history of studies on the effect of catecholamines on synaptic transmission does not answer the main question about the mechanism of their action on quantal release in the neuromuscular junction. Currently, interest in catecholamines has increased not only because of their widespread use in the clinic for the treatment of cardiovascular and pulmonary diseases but also because of recent data on their possible use for the treatment of certain neurodegenerative diseases, muscle weakness and amyotrophic sclerosis. Nevertheless, the effects and mechanisms of catecholamines on acetylcholine release remain unclear. We investigated the action of noradrenaline and adrenaline on the spontaneous and evoked quantal secretion of acetylcholine in the neuromuscular junction of the rat soleus muscle. Noradrenaline (10 µM) did not change the spontaneous acetylcholine quantal release, the number of released quanta after nerve stimulation, or the timing of the quantal secretion. However, adrenaline at the same concentration increased spontaneous secretion by 40%, increased evoked acetylcholine quantal release by 62%, and synchronized secretion. These effects differ from those previously described by us in the synapses of the frog cutaneous pectoris muscle and mouse diaphragm. This indicates specificity in catecholamine action that depends on the functional type of muscle and the need to take the targeted type of muscle into account in clinical practice.


Acetylcholine/metabolism , Epinephrine/pharmacology , Motor Neurons/metabolism , Nerve Endings/metabolism , Synaptic Transmission/physiology , Animals , Evoked Potentials/drug effects , Motor Endplate/drug effects , Motor Endplate/metabolism , Motor Neurons/drug effects , Nerve Endings/drug effects , Norepinephrine/pharmacology , Rats, Wistar , Synaptic Transmission/drug effects
14.
J Psychopharmacol ; 35(1): 40-49, 2021 01.
Article En | MEDLINE | ID: mdl-33274683

BACKGROUND: Feedback evaluation of actions and error response detection are critical for optimizing behavioral adaptation. Oxytocin can facilitate learning following social feedback but whether its effects vary as a function of feedback valence remains unclear. AIMS: The present study aimed to investigate whether oxytocin would influence responses to positive and negative feedback differentially or equivalently. METHODS: The present study employed a randomized, double-blind, placebo controlled within-subject design to investigate whether intranasal oxytocin (24 IU) influenced behavioral and evoked electrophysiological potential responses to positive or negative feedback in a probabilistic learning task. RESULTS: Results showed that oxytocin facilitated learning and this effect was maintained in the absence of feedback. Using novel stimulus pairings, we found that oxytocin abolished bias towards learning more from negative feedback under placebo by increasing accuracy for positively reinforced stimuli. Oxytocin also decreased the feedback-related negativity difference (negative minus positive feedback) during learning, further suggesting that it rendered the evaluation of positive and negative feedback more equivalent. Additionally, post-learning oxytocin attenuated error-related negativity amplitudes but increased the late error positivity, suggesting that it may lower conflict detection between actual errors and expected correct responses at an early stage of processing but at a later stage increase error awareness and motivation for avoiding them. CONCLUSIONS: Oxytocin facilitates learning and subsequent performance by rendering the impact of positive relative to negative feedback more equivalent and also by reducing conflict detection and increasing error awareness, which may be beneficial for behavioral adaption.


Adaptation, Psychological , Conditioning, Psychological , Formative Feedback , Oxytocin , Social Learning , Adaptation, Psychological/drug effects , Adaptation, Psychological/physiology , Administration, Intranasal , Conditioning, Psychological/drug effects , Conditioning, Psychological/physiology , Conflict, Psychological , Cross-Over Studies , Double-Blind Method , Drug Monitoring/methods , Electroencephalography/methods , Evoked Potentials/drug effects , Humans , Male , Oxytocin/administration & dosage , Oxytocin/pharmacokinetics , Psychotropic Drugs/administration & dosage , Psychotropic Drugs/pharmacokinetics , Reinforcement, Psychology , Social Learning/drug effects , Social Learning/physiology , Task Performance and Analysis , Young Adult
15.
Cells ; 9(12)2020 12 17.
Article En | MEDLINE | ID: mdl-33348659

Red tides involving Karenia brevis expose humans to brevetoxins (PbTxs). Oral exposition triggers neurotoxic shellfish poisoning, whereas inhalation induces a respiratory syndrome and sensory disturbances. No curative treatment is available and the pathophysiology is not fully elucidated. Protease-activated receptor 2 (PAR2), cathepsin S (Cat-S) and substance P (SP) release are crucial mediators of the sensory effects of ciguatoxins (CTXs) which are PbTx analogs. This work explored the role of PAR2 and Cat-S in PbTx-1-induced sensory effects and deciphered the signaling pathway involved. We performed calcium imaging, PAR2 immunolocalization and SP release experiments in monocultured sensory neurons or co-cultured with keratinocytes treated with PbTx-1 or P-CTX-2. We demonstrated that PbTx-1-induced calcium increase and SP release involved Cat-S, PAR2 and transient receptor potential vanilloid 4 (TRPV4). The PbTx-1-induced signaling pathway included protein kinase A (PKA) and TRPV4, which are compatible with the PAR2 biased signaling induced by Cat-S. Internalization of PAR2 and protein kinase C (PKC), inositol triphosphate receptor and TRPV4 activation evoked by PbTx-1 are compatible with the PAR2 canonical signaling. Our results suggest that PbTx-1-induced sensory disturbances involve the PAR2-TRPV4 pathway. We identified PAR2, Cat-S, PKA, and PKC that are involved in TRPV4 sensitization induced by PbTx-1 in sensory neurons.


Calcium/metabolism , Marine Toxins/pharmacology , Oxocins/pharmacology , Receptor, PAR-2/metabolism , Signal Transduction/drug effects , Substance P/metabolism , Animals , Cathepsins/genetics , Cathepsins/metabolism , Cathepsins/pharmacology , Cells, Cultured , Dipeptides/pharmacology , Evoked Potentials/drug effects , Humans , Isoxazoles/pharmacology , Keratinocytes/cytology , Keratinocytes/drug effects , Keratinocytes/metabolism , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Rats , Rats, Wistar , Receptor, PAR-2/genetics , Recombinant Proteins/biosynthesis , Recombinant Proteins/pharmacology , Sensory Receptor Cells/cytology , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/metabolism , TRPV Cation Channels/antagonists & inhibitors , TRPV Cation Channels/metabolism
16.
Acta Neurobiol Exp (Wars) ; 80(4): 411-423, 2020.
Article En | MEDLINE | ID: mdl-33350994

Human cognition may be enhanced by energy drinks containing caffeine and/or other stimulants, which are thought to improve attentional as well as motor performance, and reduce reaction times. Due to the fact that literature shows that even low doses of caffeine may improve cognitive performance, we investigated an acute effect of a single dose of a caffeinated energy dietary supplement, on attention and motor responses by means of event related potentials. Healthy volunteers were examined in double blind, placebo controlled study. EEG recordings from 32 channels were performed in three sessions: before the supplementation (session 1), 30 min after the supplementation (session 2) and 90 min after the supplementation (session 3) in three tasks: visual P3, auditory P3, and motor task. Repeated measures ANOVA analysis showed reduced P3 amplitude increase after energy dietary supplementation (compared to placebo group) throughout all sessions (up to 90 min after consumption) in the visual task, and speeding the classification process observed as a decrease of P3 midpoint latency, but only 30 min after supplementation. The latter effect was present in both, but more pronounced in the visual task. Nonparametric cluster based permutation analysis showed one significant cluster in the placebo group from visual P3 task (approximately between 400 and 520 ms) over the centro­parietal area, which was absent in the study group. Our results suggest that caffeinated energy dietary supplement containing only 55 mg of caffeine may enhance some attentional processes observed by changes in P3 features, but not in motor performance.


Attention/drug effects , Caffeine/pharmacology , Dietary Supplements , Evoked Potentials/drug effects , Adult , Attention/physiology , Caffeine/administration & dosage , Cognition/drug effects , Double-Blind Method , Electroencephalography/methods , Evoked Potentials/physiology , Female , Humans , Male , Reaction Time/drug effects , Young Adult
17.
Front Neural Circuits ; 14: 576504, 2020.
Article En | MEDLINE | ID: mdl-33224026

The retrosplenial cortex forms part of the cingulate cortex and is involved in memory and navigation. It is ventral region, the granular retrosplenial cortex, or GRSC is characterized by the presence, of small pyramidal neurons with a distinctive late-spiking (LS) firing pattern in layer 2/3. Using in vitro brain slices of the mouse GRSC we have studied the electrophysiological properties and synaptic responses of these LS neurons, comparing them with neighboring non-LS pyramidal neurons. LS and non-LS neurons showed different responses during cortical propagation of epileptiform discharges. All non-LS neurons generated large supra-threshold excitatory responses that generated bursts of action potentials. Contrastingly, the LS neurons showed small, and invariably subthreshold excitatory synaptic potentials. Although both types of pyramidal neurons were readily intermingled in the GRSC, we observed differences in their innervation by cortico-cortical axons. The application of glutamate to activate cortical neurons evoked synaptic responses in LS neurons only when applied at less than 250 µm, while in non-LS neurons we found synaptic responses when glutamate was applied at larger distances. Analysis of the synaptic responses evoked by long-range cortico-cortical axons (with the origin at 1200 µm from the recorded neurons or in the contralateral hemisphere) confirmed that non-LS neurons were strongly innervated by these axons, while they evoked only small responses or no response at all in the LS neurons (contralateral stimulation, non-LS: 194.0 ± 196.63 pA, n = 22; LS: 51.91 ± 35.26 pA, n = 10; p = 0.004). The excitatory/inhibitory balance was similar in both types of pyramidal neurons, but the latency of the EPSCs evoked by long-range cortico-cortical axons was longer in LS neurons (contralateral stimulation non-LS: 8.13 ± 1.23 ms, n = 17; LS: 10.76 ± 1.58 ms, n = 7; p = 0.004) suggesting a disynaptic mechanism. Our findings highlight the differential cortico-cortical axonal innervation of LS and non-LS pyramidal neurons, and that the two types of neurons are incorporated in different cortico-cortical neuronal circuits. This strongly suggests that the functional organization of the dorsal part of the GRSC is based on independent cortico-cortical circuits (among other elements).


Action Potentials/physiology , Excitatory Postsynaptic Potentials/physiology , Gyrus Cinguli/physiology , Neural Pathways/physiology , Pyramidal Cells/physiology , Action Potentials/drug effects , Animals , Axons , Evoked Potentials/drug effects , Evoked Potentials/physiology , Excitatory Postsynaptic Potentials/drug effects , Glutamic Acid/pharmacology , Gyrus Cinguli/cytology , Gyrus Cinguli/drug effects , In Vitro Techniques , Mice , Neural Pathways/cytology , Neural Pathways/drug effects , Pyramidal Cells/drug effects
18.
PLoS One ; 15(11): e0242056, 2020.
Article En | MEDLINE | ID: mdl-33226992

How and to what extent electrical brain activity reflects pharmacologically altered states and contents of consciousness, is not well understood. Therefore, we investigated whether measures of evoked and spontaneous electroencephalographic (EEG) signal diversity are altered by sub-anaesthetic levels of ketamine compared to normal wakefulness, and how these measures relate to subjective experience. High-density 62-channel EEG was used to record spontaneous brain activity and responses evoked by transcranial magnetic stimulation (TMS) in 10 healthy volunteers before and during administration of sub-anaesthetic doses of ketamine in an open-label within-subject design. Evoked signal diversity was assessed using the perturbational complexity index (PCI), calculated from EEG responses to TMS perturbations. Signal diversity of spontaneous EEG, with eyes open and eyes closed, was assessed by Lempel Ziv complexity (LZc), amplitude coalition entropy (ACE), and synchrony coalition entropy (SCE). Although no significant difference was found in TMS-evoked complexity (PCI) between the sub-anaesthetic ketamine condition and normal wakefulness, all measures of spontaneous EEG signal diversity (LZc, ACE, SCE) showed significantly increased values in the sub-anaesthetic ketamine condition. This increase in signal diversity correlated with subjective assessment of altered states of consciousness. Moreover, spontaneous signal diversity was significantly higher when participants had eyes open compared to eyes closed, both during normal wakefulness and during influence of sub-anaesthetic ketamine. The results suggest that PCI and spontaneous signal diversity may reflect distinct, complementary aspects of changes in brain properties related to altered states of consciousness: the brain's capacity for information integration, assessed by PCI, might be indicative of the brain's ability to sustain consciousness, while spontaneous complexity, as measured by EEG signal diversity, may be indicative of the complexity of conscious content. Thus, sub-anaesthetic ketamine may increase the complexity of the conscious content and the brain activity underlying it, while the level or general capacity for consciousness remains largely unaffected.


Brain/physiology , Electroencephalography/drug effects , Hallucinogens/administration & dosage , Ketamine/administration & dosage , Adult , Brain/drug effects , Entropy , Evoked Potentials/drug effects , Female , Hallucinogens/pharmacology , Healthy Volunteers , Humans , Ketamine/pharmacology , Male , Transcranial Magnetic Stimulation/drug effects , Wakefulness/physiology , Young Adult
19.
Int J Mol Sci ; 21(20)2020 Oct 10.
Article En | MEDLINE | ID: mdl-33050414

Long-chain acylcarnitines (LCAC) are implicated in ischemia-reperfusion (I/R)-induced myocardial injury and mitochondrial dysfunction. Yet, molecular mechanisms underlying involvement of LCAC in cardiac injury are not sufficiently studied. It is known that in cardiomyocytes, palmitoylcarnitine (PC) can induce cytosolic Ca2+ accumulation, implicating L-type calcium channels, Na+/Ca2+ exchanger, and Ca2+-release from sarcoplasmic reticulum (SR). Alternatively, PC can evoke dissipation of mitochondrial potential (ΔΨm) and mitochondrial permeability transition pore (mPTP). Here, to dissect the complex nature of PC action on Ca2+ homeostasis and oxidative phosphorylation (OXPHOS) in cardiomyocytes and mitochondria, the methods of fluorescent microscopy, perforated path-clamp, and mitochondrial assays were used. We found that LCAC in dose-dependent manner can evoke Ca2+-sparks and oscillations, long-living Ca2+ enriched microdomains, and, finally, Ca2+ overload leading to hypercontracture and cardiomyocyte death. Collectively, PC-driven cardiotoxicity involves: (I) redistribution of Ca2+ from SR to mitochondria with minimal contribution of external calcium influx; (II) irreversible inhibition of Krebs cycle and OXPHOS underlying limited mitochondrial Ca2+ buffering; (III) induction of mPTP reinforced by PC-calcium interplay; (IV) activation of Ca2+-dependent phospholipases cPLA2 and PLC. Based on the inhibitory analysis we may suggest that simultaneous inhibition of both phospholipases could be an effective strategy for protection against PC-mediated toxicity in cardiomyocytes.


Calcium/metabolism , Cardiotoxicity/etiology , Cardiotoxicity/metabolism , Carnitine/analogs & derivatives , Mitochondria, Heart/metabolism , Myocytes, Cardiac/metabolism , Phospholipases/metabolism , Calcium Signaling , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Carnitine/metabolism , Carnitine/pharmacology , Evoked Potentials/drug effects , Homeostasis , Mitochondria, Heart/drug effects , Muscle Cells/metabolism , Sarcoplasmic Reticulum/metabolism , Sodium/metabolism
20.
Psychopharmacology (Berl) ; 237(11): 3383-3397, 2020 Nov.
Article En | MEDLINE | ID: mdl-32944790

RATIONALE: Alcohol intoxication can dampen negative affective reactions to stressors. Recently, it has been proposed that these acute anxiolytic effects of alcohol may extend to dampening of negative affective reactions to error commission during cognitive control tasks. Nonetheless, empirical verification of this claim is lacking. OBJECTIVES: Test the acute effect of alcohol on negative affective reactions to errors during an effort-demanding cognitive control task. METHODS: Healthy, young adult social drinkers (N = 96 [49 women], 21-36 years old) were randomly assigned to consume alcohol (0.80 g/kg; n = 33 [15 female]), active placebo (0.04 g/kg; n = 33 [18 women]), or a non-alcoholic control beverage (n = 30 [16 women]) before completing the Eriksen flanker task. Corrugator supercilii (Corr) activation, a psychophysiological index of negative affect, was tracked across the task. Two neurophysiological reactions to errors, the error-related negativity (ERN) and the error positivity (Pe), were also measured. RESULTS: Erroneous actions increased Corr activation in the control and (to a lesser extent) placebo groups, but not in the alcohol group. Error-induced Corr activation was coupled to ERN and Pe in the control, but not in the alcohol and placebo groups. Error-induced Corr activation was not coupled to post-error performance adjustments in any group. CONCLUSIONS: The ability of alcohol to dampen error-related negative affect was verified. It was also shown that placebo alone can disrupt coupling of affective and (neuro)cognitive reactions to errors. Although its behavioral relevance remains to be demonstrated, more attention should be paid to the role of affect in action monitoring and cognitive control processes.


Alcoholic Beverages , Cognition/drug effects , Psychomotor Performance/drug effects , Reaction Time/drug effects , Adult , Alcohol Drinking/psychology , Alcohol Drinking/trends , Cognition/physiology , Electroencephalography/drug effects , Electroencephalography/methods , Evoked Potentials/drug effects , Evoked Potentials/physiology , Female , Humans , Male , Psychomotor Performance/physiology , Random Allocation , Reaction Time/physiology , Young Adult
...